These outcomes not only provided scientists with additional knowledge about the physiological roles of insulin in metabolism and body weight regulation, but also paved the way for the ongoing advances in anti-obesity medications. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.